Immunotherapy: changing the face of melanoma treatment | TRM CancerBRC
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Cancer: Scientists aim to double survival within a decade | The Independent
SAB and I-O AB - T3 Pharma
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
PATRIOT: ATR inhibitor monotherapy in advanced solid tumors | VJOncology
Professor Kevin Harrington - The Institute of Cancer Research, London
Radiotherapy Theme on Vimeo
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Kevin Harrington, PhD on Importance of KEYNOTE-048 #ASCO2020 #ASCO
The Royal Marsden NHS Foundation Trust on Twitter: "Huge congratulations Professors David Cunningham, Johann De Bono, Kevin Harrington, Nicholas Turner, Mitch Dowsett, James Larkin! #HighlyCited2021" / Twitter
GM herpes virus fights advanced cancers
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
Potential of immunotherapy in head and neck cancer | VJOncology
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
Professor Kevin Harrington | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Advisory Board | Nanobiotix
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Professor Kevin Harrington - The Institute of Cancer Research, London
